- About us
- Join Putnam
Client needed help to support development of local medical launch readiness plans including local medical objectives, competitive positioning, scientific narrative, and data generation, and stakeholder engagement strategy for a new vaccine.
We developed a framework to systematically assess medical planning for the asset that included the medical objectives, competitive positioning, scientific narrative, data generation, and stakeholder engagement. Country-specific syntheses of strategic considerations were developed to inform medical planning. The significance and feasibility of supporting the asset scientific narratives were considered by country.
We provided an executive summary of the asset’s medical objectives, key scientific narratives, gaps and potential challenges, country action plans, and implications for regional and global.
Putnam PHMR’s client needed a detailed description of multiple myeloma treatment patterns and resource utilization in Japanese patients...
An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.
A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology.